Metropolis Healthcare Ltd share price logo

Metropolis Healthcare Ltd Share Price

(METROPOLIS)

₹1704.82.52%

as on 04:01PM, 29 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Metropolis Healthcare Ltd Performance

  • Day's Low

    Day's High

    ₹1,700
    Day's Price Range
    ₹1,753.9
  • 52 Week's Low

    52 Week's High

    ₹1,315
    52-Week Price Range
    ₹2,318.3
1 Month Return+ 11.78 %
3 Month Return-5.53 %
1 Year Return-6.21 %
Previous Close₹1,748.80
Open₹1,748.80
Volume23.80K
Upper Circuit₹2,098.50
Lower Circuit₹1,399.10
Market Cap₹8,742.41Cr

Metropolis Healthcare Ltd Fundamentals

P/E Ratio

57.36

PEG Ratio

10.68

Market Cap

₹8,742.41 Cr

P/B Ratio

8.58

EPS

25.08

Dividend Yield

0.23

Sector

Healthcare

ROE

11.78

Metropolis Healthcare Ltd Analyst Rating

based on 18 analysts

BUY

66.67%

Buy

5.56%

Hold

27.78%

Sell

Based on 18 analysts offering long term price targets for Metropolis Healthcare Ltd. An average target of ₹2061.39

Source: S&P Global Market Intelligence

Metropolis Healthcare Ltd Share analysis

Metropolis Healthcare Ltd price forecast by 18 analysts

Upside of20.92%

High

₹2740

Target

₹2061.39

Low

₹1675

Metropolis Healthcare Ltd target price ₹2061.39, a slight upside of 20.92% compared to current price of ₹1704.8. According to 18 analysts rating.

Source: S&P Global Market Intelligence

Key events for Metropolis Healthcare Ltd

  • Diagnostic Sector Shows Resilience and Potential Consolidation - 24 Apr, 2025

    Incumbents like Dr. Lal and Metropolis have regained margins to pre-COVID levels, indicating a positive outlook. However, consolidation in the diagnostic industry remains infrequent due to scale considerations.
  • Metropolis Healthcare Faces Near-Term Challenges - 10 Apr, 2025

    Metropolis Healthcare's stock has declined 21% over three months due to weak performance, earnings revisions, and regulatory concerns. Anticipated disappointing Q4 results and lower revenue growth add to the pressure, although some brokerages believe the stock has fully discounted these issues.
  • Metropolis Expands Northern Presence with Acquisition - 07 Apr, 2025

    Metropolis Healthcare has acquired Dr. Ahujas Pathology and Imaging Centre for ₹35 crore, enhancing its footprint in North India. This acquisition aligns with its growth strategy and aims to boost revenue and service offerings in the region.
  • Metropolis Healthcare Reports 10% Revenue Growth in Q4 FY25 - 05 Apr, 2025

    Metropolis Healthcare achieved a 10% year-on-year revenue growth in Q4 FY25, driven by its wellness segment, despite challenges in acute testing and specialty areas. The B2C business saw a 14% revenue increase, while operational EBITDA faced constraints from higher material costs. The company remains debt-free with cash reserves of Rs 112 crore, despite acquisition-related expenses.

Insights on Metropolis Healthcare Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 3.87% to 5.52% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, METROPOLIS stock has moved up by 14.7%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 26.37% to 26.42% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Fortis Healthcare Ltd has given 52.4% return, outperforming this stock by 54.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 165.8% return, outperforming this stock by 192.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 46.52 Cr → 31.36 Cr (in ₹), with an average decrease of 32.6% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 352.92 Cr → 325.32 Cr (in ₹), with an average decrease of 7.8% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 49.40% to 48.90% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 16.73% to 15.29% in Mar 2025 quarter

Metropolis Healthcare Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹291.12Cr (-)₹331.00Cr (↑13.70%)₹313.36Cr (↓5.33%)₹349.79Cr (↑11.63%)₹322.77Cr (↓7.72%)
Net Income₹27.29Cr (-)₹36.53Cr (↑33.86%)₹38.11Cr (↑4.33%)₹46.70Cr (↑22.54%)₹31.47Cr (↓32.61%)
Net Profit Margin9.37% (-)11.04% (↑17.82%)12.16% (↑10.14%)13.35% (↑9.79%)9.75% (↓26.97%)
Value in ₹ crore
Details2021202220232024
Total Assets₹953.48Cr (-)₹1,458.55Cr (↑52.97%)₹1,452.32Cr (↓0.43%)₹1,495.33Cr (↑2.96%)
Total Liabilities₹288.67Cr (-)₹619.35Cr (↑114.55%)₹516.31Cr (↓16.64%)₹464.14Cr (↓10.10%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹156.13Cr (-)₹236.23Cr (↑51.30%)₹244.04Cr (↑3.31%)₹237.74Cr (↓2.58%)₹269.01Cr (↑13.15%)

Metropolis Healthcare Ltd Index Inclusions

S&P BSE 400 MidSmallCap

₹11,199.56

0.25 (27.99%)

BSE Healthcare

₹42,211.90

-0.81 (-343.75%)

BSE 500

₹34,785.55

0.06 (19.76%)

Nifty MidSmallcap 400

₹18,431.30

0.21 (38.8%)

S&P BSE 250 SmallCap

₹6,272.53

0.23 (14.55%)

Nifty Smallcap 250

₹15,639.70

0.21 (32.55%)

Nifty 500

₹22,112.40

0.05 (10.55%)

BSE Small-Cap

₹48,238.69

0.09 (45.23%)

Metropolis Healthcare Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
48.9%
0.00
Foreign Institutions
15.29%
0.00
Mutual Funds
26.42%
0.00
Retail Investors
5.52%
0.00
Others
3.88%
0.00

Metropolis Healthcare Ltd Key Indicators

Details20202021202220232024
Earning Per Share (₹)25.1935.8741.952825.08
Details20202021202220232024
Return On Equity %27.9631.0326.5315.6511.78
Details20202021202220232024
Return On Assets %18.1319.214.689.848.55
Details20202021202220232024
Book Value Per Share (₹)103.4138.23173.18192.97213.98

Metropolis Healthcare Ltd Valuation

Metropolis Healthcare Ltd in the last 5 years

  • Overview

  • Trends

Lowest (33.38x)

June 22, 2022

Today (57.36x)

April 29, 2025

Industry (101.93x)

April 29, 2025

Highest (98.05x)

September 15, 2020

LowHigh

Metropolis Healthcare Ltd Earnings and Dividends

  • Metropolis Healthcare Ltd Earnings Results

    Metropolis Healthcare Ltd’s net profit jumped 15.46% since last year same period to ₹31.36Cr in the Q3 2024-2025. On a quarterly growth basis, Metropolis Healthcare Ltd has generated -32.59% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Metropolis Healthcare Ltd Dividends November,2023

    In the quarter ending September 2023, Metropolis Healthcare Ltd has declared dividend of ₹4 - translating a dividend yield of 0.70%.

    Read More about Dividends

Metropolis Healthcare Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Metropolis Healthcare Ltd is currently in a Bullish trading position according to technical analysis indicators.

Metropolis Healthcare Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹8,742.41 Cr7%0.58₹128 Cr₹1,207 Cr
BUY₹10,434.00 Cr12.79%0.64₹119 Cr₹547 Cr
BUY₹4,717.74 Cr15%0.54₹69 Cr₹571 Cr
HOLD₹23,220.11 Cr15.03%0.55₹362 Cr₹2,226 Cr
HOLD₹33,296.15 Cr100.48%0.67₹168 Cr₹5,040 Cr

About Metropolis Healthcare Ltd

Metropolis Healthcare Ltd is an Indian diagnostic chain incorporated in April 2015. Metropolis Healthcare Ltd offers a comprehensive range of diagnostic services, ranging from routine tests to specialized tests. It operates in major cities across India, with a presence in over 170 cities and towns.

The company offers a wide range of products and services, including clinical laboratory services, imaging services, pathology services, and wellness services. Metropolis Healthcare Ltd also provides a range of specialty services, such as genetic testing, molecular diagnostics, and bio-banking. It is one of the leading providers of healthcare services in India.

The company's top products include clinical laboratory tests, imaging services, pathology services, and wellness services. It also offers a range of popular services under the brands: Metropolis, Metropolis Health Plus, Metropolis Health Care, and Metropolis Health Care Plus.

Revenue: ₹322.77Cr as on December 2024 (Q4 24)
Net Profit: ₹31.47Cr as on December 2024 (Q4 24)
Listing date: 15 Apr, 2019
Chairperson Name: Sushil Kanubhai Shah
OrganisationMetropolis Healthcare Ltd
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Metropolis Healthcare Ltd

What is Metropolis Healthcare Ltd price today?

Metropolis Healthcare Ltd share price today stands at ₹1704.8, Open: ₹1748.8, Previous Close: ₹1748.8, High: ₹1753.9, Low: ₹1700, 52 Week High: ₹2318.3, 52 Week Low: ₹1315.

How to Buy Metropolis Healthcare Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Metropolis Healthcare Ltd shares

What are today's traded volumes of Metropolis Healthcare Ltd?

Today's traded volume of Metropolis Healthcare Ltd(METROPOLIS) is 23.80K.

What is today's market capitalisation of Metropolis Healthcare Ltd?

Today's market capitalisation of Metropolis Healthcare Ltd(METROPOLIS) is ₹8742.41Cr.

What is the 52 Week High and Low Range of Metropolis Healthcare Ltd?

Metropolis Healthcare Ltd (METROPOLIS)
Price
52 Week High
₹2318.3
52 Week Low
₹1315

How much percentage Metropolis Healthcare Ltd is down from its 52 Week High?

Metropolis Healthcare Ltd (METROPOLIS) share price is ₹1704.8. It is down -26.46% from its 52 Week High price of ₹2318.3

How much percentage Metropolis Healthcare Ltd is up from its 52 Week low?

Metropolis Healthcare Ltd (METROPOLIS) share price is ₹1704.8. It is up 29.64% from its 52 Week Low price of ₹1315